Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06456541 · ClinicalTrials.gov registry record · NA

Infant Formula in Infants and Children With Cow's Milk Allergy

A NA study of Cow's Milk Allergy, sponsored by Abbott Nutrition.

Recruiting
Registry status
NA
Development phase
61
Enrollment target
8
Study locations

NCT06456541 is a NA study of Cow's Milk Allergy that is actively recruiting participants, run by Abbott Nutrition. The registered enrollment target is 61 participants. The trial reports 8 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06456541, a NA study of Cow's Milk Allergy, is actively recruiting participants, sponsored by Abbott Nutrition.

RECRUITING
Registry status
NA
Development phase
61 participants
Enrollment target
8
Study locations

Study Summary

This is a multi-center, randomized, double-blinded, placebo-controlled food challenge to be conducted in infants and children with confirmed IgE-mediated cow's milk allergy (CMA), followed by a 7-day open feeding of the experimental formula.

Conditions Studied

Interventions

  • OTHER Experimental Extensively Hydrolyzed Formula
  • OTHER Placebo Extensively Hydrolyzed Formula

Study Locations (8)

Ohio

  • Cincinnati Children's Hospital Medical Center - Cincinnati
  • Cleveland Clinic - Cleveland
  • Nationwide Children's Hospital - Columbus

Colorado

  • Children's Hospital Colorado - Aurora

Illinois

  • Ann & Robert H. Lurie Children's Hospital of Chicago - Chicago

Michigan

  • University of Michigan Food Allergy Clinic - Ann Arbor

North Carolina

  • University of North Carolina at Chapel Hill - Chapel Hill

Texas

  • UT Southwestern Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 61 participants
Start Date 2024-10-01
Est. Completion 2029-01
Phase NA

Sponsor

Abbott Nutrition

89 total trials

What the Registry Record Tells You About NCT06456541

The ClinicalTrials.gov registry entry for NCT06456541 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Nutrition, which has 89 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cow's Milk Allergy appearing as the primary indexed condition, and to 2 interventions - of which Experimental Extensively Hydrolyzed Formula is the first listed.

NCT06456541 reports 8 study locations spanning 6 distinct geographic areas - top geographies include Ohio, Colorado, Illinois.

Frequently Asked Questions

What is clinical trial NCT06456541 about?

NCT06456541 is a clinical study titled "Infant Formula in Infants and Children With Cow's Milk Allergy". This is a multi-center, randomized, double-blinded, placebo-controlled food challenge to be conducted in infants and children with confirmed IgE-mediated cow's milk allergy (CMA), followed by a 7-day open feeding of the experimental formula.

What is the current status of trial NCT06456541?

This trial is currently recruiting. It is a NA study. The enrollment target is 61 participants. The study started on 2024-10-01. Estimated completion is 2029-01.

What conditions does trial NCT06456541 study?

This clinical trial studies the following conditions: Cow's Milk Allergy.

What interventions are being tested in trial NCT06456541?

The interventions under investigation include: Experimental Extensively Hydrolyzed Formula (OTHER), Placebo Extensively Hydrolyzed Formula (OTHER).

Who is sponsoring clinical trial NCT06456541?

This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06456541 being conducted?

This trial has 8 study locations across Colorado, Illinois, Michigan, North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.